3.24
price up icon3.51%   0.11
after-market Dopo l'orario di chiusura: 3.23 -0.01 -0.31%
loading
Precedente Chiudi:
$3.13
Aprire:
$3.2195
Volume 24 ore:
33,781
Relative Volume:
0.02
Capitalizzazione di mercato:
$10.45M
Reddito:
$12.99M
Utile/perdita netta:
$-23.72M
Rapporto P/E:
-0.0333
EPS:
-97.2514
Flusso di cassa netto:
$-23.28M
1 W Prestazione:
+6.93%
1M Prestazione:
-0.31%
6M Prestazione:
-96.49%
1 anno Prestazione:
-98.95%
Intervallo 1D:
Value
$3.20
$3.28
Intervallo di 1 settimana:
Value
$2.93
$3.28
Portata 52W:
Value
$2.81
$381.10

Aptevo Therapeutics Inc Stock (APVO) Company Profile

Name
Nome
Aptevo Therapeutics Inc
Name
Telefono
206-838-0500
Name
Indirizzo
2401 4TH AVE., SEATTLE, WA
Name
Dipendente
37
Name
Cinguettio
@aptevo
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
APVO's Discussions on Twitter

Confronta APVO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
APVO
Aptevo Therapeutics Inc
3.24 10.09M 12.99M -23.72M -23.28M -97.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2018-11-05 Iniziato Ladenburg Thalmann Buy
2017-10-05 Ripresa Piper Jaffray Overweight

Aptevo Therapeutics Inc Borsa (APVO) Ultime notizie

pulisher
12:10 PM

What analysts say about Aptevo Therapeutics Inc. stockDynamic profit opportunities - Autocar Professional

12:10 PM
pulisher
Jul 23, 2025

Aptevo Therapeutics Inc. Stock Analysis and ForecastRecord-setting profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Aptevo Therapeutics Inc. a good long term investmentExceptional market positioning - Autocar Professional

Jul 23, 2025
pulisher
Jul 19, 2025

What drives Aptevo Therapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 16, 2025

Aptevo Meets Nasdaq $2.5M Equity Requirement - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Aptevo Therapeutics Inc. stock price move sharplyFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Aptevo Therapeutics Inc. stock attracts strong analyst attentionFree Elite Traders Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Aptevo Therapeutics Inc. stock performs during market volatility2x 3x 5x Pick Alert - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

10 Best Get Rich Quick Stocks to Buy Now - Insider Monkey

Jul 11, 2025
pulisher
Jul 02, 2025

Aptevo regains Nasdaq compliance following $15.9 million equity raise By Investing.com - Investing.com India

Jul 02, 2025
pulisher
Jul 01, 2025

Aptevo Therapeutics Regains Nasdaq Compliance with Equity Raise - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Aptevo regains Nasdaq compliance following $15.9 million equity raise - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

Aptevo Therapeutics Raises $15.9M to Meet Nasdaq Compliance - TipRanks

Jun 30, 2025
pulisher
Jun 24, 2025

Aptevo Therapeutics' Mysterious 10% Spike: What’s Behind the Surge? - AInvest

Jun 24, 2025
pulisher
Jun 23, 2025

Aptevo (APVO) appoints Baker Tilly as auditor after Moss Adams merger - Stock Titan

Jun 23, 2025
pulisher
Jun 22, 2025

Aptevo Therapeutics Plummets 18%: A Technical & Order-Flow Deep Dive - AInvest

Jun 22, 2025
pulisher
Jun 21, 2025

Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous - Benzinga

Jun 21, 2025
pulisher
Jun 20, 2025

Top Medical Stocks To Watch Today – June 18th - Defense World

Jun 20, 2025
pulisher
Jun 19, 2025

Aptevo Therapeutics Surges 82% Amid No Fundamental News—What’s Driving the Spike? - AInvest

Jun 19, 2025
pulisher
Jun 18, 2025

Top Small Cap Stocks Worth WatchingJune 18th - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Crude Oil Moves Higher; US Weekly Jobless Claims Decline - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics raises $8 million in registered direct offering - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

Dow Surges 150 Points; Korn Ferry Earnings Top Views - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Secures $8M Through Direct Offering - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics announces $8M at-the-market equity offering with warrants; shares more than double - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics raises $8 million in registered direct offering By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Why Is Micro-Cap Aptevo Stock Trading Higher On Wednesday?Aptevo Therapeutics (NASDAQ:APVO) - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules | APVO Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

An early stage 85% remissions rate in AML drives Aptevo’s stock surge - BioWorld MedTech

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules - ACCESS Newswire

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Secures $8M Funding: Biotech Company Accelerates Cancer Drug Development Pipeline - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics stock soars after impressive AML treatment results - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics stock soars after impressive AML treatment results By Investing.com - Investing.com Canada

Jun 18, 2025
pulisher
Jun 18, 2025

Why did Aptevo Therapeutics Shares Skyrocket in Premarket Trading Today? - Tokenist

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Skyrockets on Game-Changing AML Drug News - RagingBull

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo reports 85% remission rate in frontline AML trial By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Shows Promising Results in RAINIER Tr - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Says Its Mipletamig Therapy Achieves 85% Remission Rate in Leukemia Patients; Shares Soar Pre-Bell - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Shows Promising Results in AML Trial - GuruFocus

Jun 18, 2025

Aptevo Therapeutics Inc Azioni (APVO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):